| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_360aecc03567ff4ccb202a66b2cc24d0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 |
| filingDate |
2015-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e15ce1526b764168f46b20715f604614
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73f1bab3419f482216e6ffed56ee08a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4923f215ce875a73fc7bf5f9f0f363ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bda1d1b23b2e259bdf12e2e2813271bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffa923e43bbf5796eb2a976955be903f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d71a878354c0761e58b5a61216a92c4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb2a31a088efcc22670d343aadcc340b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc9245aeb729964ee4ad05172da710f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4857274b9d68204cdb50165bc0c0d9a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23c6e786df7156a096b66b6b1f5fc682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af86721668e040ff4cde4c5e02fd80fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e5dd2d0d2182986819344a3eb6df6e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82aff954bf766176c7d6f7194164cb9a |
| publicationDate |
2016-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016110167-A1 |
| titleOfInvention |
Applications of 20(r)-ginsenosides rg3 in preparing medicament or healthcare product for use in treatment of osteoporosis and medicament |
| abstract |
Applications of 20(R)-ginsenosides Rg3 in preparing a medicament for use in treatment of osteoporosis and the medicament or a healthcare product comprising 20(R)-ginsenosides Rg3, where the content of 20(R)-ginsenosides Rg3 is ≥ 1%. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110496131-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110496131-B |
| priorityDate |
2015-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |